• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植幸存者和临床医生使用生存护理计划的障碍和促进因素。

Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians.

机构信息

University of Wisconsin, Madison, WI, USA.

Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.

出版信息

Support Care Cancer. 2022 Feb;30(2):1323-1330. doi: 10.1007/s00520-021-06492-3. Epub 2021 Sep 5.

DOI:10.1007/s00520-021-06492-3
PMID:34482447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8732291/
Abstract

PURPOSE

Survivors of hematopoietic stem cell transplants (HSCT) have complex care needs for the remainder of their lives, known as the survivorship period. Survivorship care plans (SCPs) have been proposed to improve care coordination and ultimately survivorship outcomes. We explored the barriers and facilitators of SCP use among HSCT survivors and their clinicians in order to develop more useful SCPs for the HSCT context.

METHODS

Analogous surveys regarding perceived barriers to and facilitators of SCP use based on a sample SCP for a female allogenic HSCT survivor were administered to HSCT survivors and non-transplant oncology and primary care clinicians.

RESULTS

Twenty-seven HSCT survivors and 18 clinicians completed the survey. The main barriers to SCP use were lack of awareness of SCP existence, uncertainty regarding where to find SCP, unclear roles and responsibilities among healthcare teams, length of SCP, and difficultly understanding SCPs. The facilitators of SCP use were increased understanding of survivorship care needs, clarified roles and responsibilities of survivors and clinicians, SCPs that are readily available and searchable in electronic health record, increased awareness of SCP existence and provision to all survivors, and if the SCP is survivor-specific and up-to-date.

CONCLUSIONS

Much of the work regarding SCPs has looked at barriers to creation and provision; however, our study examines factors influencing use of SCPs. By determining the barriers and facilitators surrounding SCP use for HSCT survivors and their clinicians, we can create SCP templates and clinical workflows to optimize SCP use, ideally leading to better outcomes for HSCT survivors.

摘要

目的

造血干细胞移植(HSCT)幸存者在其余生中都有复杂的护理需求,这被称为生存期间。生存护理计划(SCP)的提出是为了改善护理协调,最终改善生存结果。我们旨在探索 HSCT 幸存者及其临床医生使用 SCP 的障碍和促进因素,以便为 HSCT 环境开发更有用的 SCP。

方法

根据女性异基因 HSCT 幸存者的样本 SCP,对 HSCT 幸存者和非移植肿瘤学和初级保健临床医生进行了类似的关于使用 SCP 的感知障碍和促进因素的调查。

结果

27 名 HSCT 幸存者和 18 名临床医生完成了调查。使用 SCP 的主要障碍是缺乏对 SCP 存在的认识、对在哪里找到 SCP 的不确定性、医疗团队之间角色和责任不明确、SCP 长度以及难以理解 SCP。使用 SCP 的促进因素包括对生存护理需求的理解增加、幸存者和临床医生的角色和责任明确、SCP 易于在电子健康记录中搜索和获取、对 SCP 存在和向所有幸存者提供的意识提高、以及 SCP 是否针对幸存者且是最新的。

结论

关于 SCP 的大部分工作都集中在创建和提供的障碍上;然而,我们的研究考察了影响 SCP 使用的因素。通过确定 HSCT 幸存者及其临床医生使用 SCP 的障碍和促进因素,我们可以创建 SCP 模板和临床工作流程,以优化 SCP 的使用,理想情况下为 HSCT 幸存者带来更好的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a473/8732291/9b45bb3422f2/nihms-1747635-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a473/8732291/e6eeee56fb92/nihms-1747635-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a473/8732291/9b45bb3422f2/nihms-1747635-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a473/8732291/e6eeee56fb92/nihms-1747635-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a473/8732291/9b45bb3422f2/nihms-1747635-f0002.jpg

相似文献

1
Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians.造血干细胞移植幸存者和临床医生使用生存护理计划的障碍和促进因素。
Support Care Cancer. 2022 Feb;30(2):1323-1330. doi: 10.1007/s00520-021-06492-3. Epub 2021 Sep 5.
2
Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.造血干细胞移植患者生存者和临床医生对生存者护理计划的评估:一个针对生存者健康的工程学、初级保健和肿瘤学协作。
Biol Blood Marrow Transplant. 2019 Jun;25(6):1240-1246. doi: 10.1016/j.bbmt.2019.02.003. Epub 2019 Feb 11.
3
Barriers and facilitators to implementing cancer survivorship care plans.实施癌症幸存者护理计划的障碍与促进因素。
Oncol Nurs Forum. 2013 Nov;40(6):575-80. doi: 10.1188/13.ONF.575-580.
4
Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice.社区肿瘤医疗实践中生存护理计划及规划对乳腺癌、结肠癌和前列腺癌幸存者的影响
J Cancer Educ. 2020 Apr;35(2):249-255. doi: 10.1007/s13187-018-1457-y.
5
Re-engineering Survivorship Care Plans to Support Primary Care Needs and Workflow: Results From an Engineering, Primary Care and Oncology Collaborative for Survivorship Health (EPOCH).重新设计生存护理计划以满足初级保健需求和工作流程:来自生存健康工程、初级保健和肿瘤学协作组织(EPOCH)的结果。
J Cancer Educ. 2022 Dec;37(6):1654-1661. doi: 10.1007/s13187-021-02008-z. Epub 2021 Apr 26.
6
Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes.癌症患者生存护理计划:护理计划结果的 Meta 分析和系统评价。
Oncologist. 2020 Feb;25(2):e351-e372. doi: 10.1634/theoncologist.2019-0184. Epub 2019 Oct 25.
7
The Impact of a Primary Care Education Program Regarding Cancer Survivorship Care Plans: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.一项关于癌症幸存者护理计划的初级保健教育项目的影响:一项针对幸存者健康的工程、初级保健和肿瘤学协作研究的结果。
J Cancer Educ. 2019 Feb;34(1):154-160. doi: 10.1007/s13187-017-1281-9.
8
Survivorship care plans: is there buy-in from community oncology providers?生存护理计划:社区肿瘤学提供者是否认同?
Cancer. 2014 Mar 1;120(5):722-30. doi: 10.1002/cncr.28472. Epub 2013 Dec 10.
9
Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider.确定癌症幸存者与医疗服务提供者分享生存护理计划的障碍。
J Cancer Surviv. 2018 Oct;12(5):632-638. doi: 10.1007/s11764-018-0699-3. Epub 2018 Jul 3.
10
An Assessment to Inform Pediatric Cancer Provider Development and Delivery of Survivor Care Plans.一项为儿科癌症医疗服务提供者制定和提供幸存者护理计划提供参考的评估。
J Cancer Educ. 2015 Dec;30(4):677-84. doi: 10.1007/s13187-015-0829-9.

引用本文的文献

1
Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects.正式造血细胞移植生存者计划对晚期效应筛查的结果。
Transplant Cell Ther. 2024 Jul;30(7):700-711. doi: 10.1016/j.jtct.2024.04.018. Epub 2024 Apr 27.
2
Analysis of Peripheral Blood Mononuclear Cells Gene Expression Highlights the Role of Extracellular Vesicles in the Immune Response following Hematopoietic Stem Cell Transplantation in Children.外周血单个核细胞基因表达分析突出了细胞外囊泡在儿童造血干细胞移植后免疫反应中的作用。
Genes (Basel). 2021 Dec 17;12(12):2008. doi: 10.3390/genes12122008.

本文引用的文献

1
Patient Perceptions of Survivorship Care Plans: A Mixed-Methods Evaluation.患者对癌症生存护理计划的认知:一项混合方法评估
Oncol Nurs Forum. 2019 Jul 1;46(4):493-502. doi: 10.1188/19.ONF.493-502.